SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IGGI (IGG International)with 5.25Billion market? -- Ignore unavailable to you. Want to Upgrade?

To: Andrew G. who wrote (80)11/10/1997 5:45:00 PM
From: rocket  Read Replies (1) | Respond to of 96
 
Andrew, thanks for your note. We are now at a 52 week high at the close today which is a bullish sign. the anticancer agent in phase i trials at M D Anderson will be undergoing clinical trials for several years, even with the FDA's fast track approval process. However, the potential for the drug may be huge. For now, I am very pleased the EPA has seen fit to give Elexa the go ahead as I see it as a significant improvement in environmentally-friendly science. karl



To: Andrew G. who wrote (80)11/24/1997 6:33:00 PM
From: Bernard Elbaum  Read Replies (1) | Respond to of 96
 
Do we know whether or not Elexa will work as a fungicide if used widely? The risk I'm concerned about is that the fungi will mutate fi Elexa is used widely and new fungi that are immune to Elexi will attack the plants.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News